Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • and disease (1)
  • brain (1)
  • female (1)
  • function (1)
  • humans (1)
  • male (1)
  • patients (5)
  • plasmapheresis (1)
  • regions (1)
  • shiga toxin 2 (7)
  • symptoms mild (1)
  • thalamus (3)
  • women (3)
  • Sizes of these terms reflect their relevance to your search.

    The underlying pathophysiology of neurological complications in patients with hemolytic-uremic syndrome (HUS) remains unclear. It was recently attributed to a direct cytotoxic effect of Shiga toxin 2 (Stx2) in the thalamus. Conventional MRI of patients with Stx2-caused HUS revealed - despite severe neurological symptoms - only mild alterations if any, mostly in the thalamus. Against this background, we questioned: Does diffusion tensor imaging (DTI) capture the thalamic damage better than conventional MRI? Are neurological symptoms and disease course better reflected by thalamic alterations as detected by DTI? Are other brain regions also affected? Three women with serious neurological deficits due to Stx2-associated HUS were admitted to MRI/DTI at disease onset. Two of them were longitudinally examined. Fractional anisotropy (FA) and mean diffusivity were computed to assess Stx2-caused microstructural damage. Compared to 90 healthy women, all three patients had significantly reduced thalamic FA. Thalamic mean diffusivity was only reduced in two patients. DTI of the longitudinally examined women demonstrated slow normalization of thalamic FA, which was paralleled by clinical improvement. Whereas conventional MRI only shows slight alterations based on subjective evaluation, DTI permits quantitative, objective, and longitudinal assessment of cytotoxic cerebral damage in individual patients. Copyright © 2015 Elsevier B.V. All rights reserved.

    Citation

    Julia Krämer, Michael Deppe, Kerstin Göbel, Karsten Tabelow, Heinz Wiendl, Sven G Meuth. Recovery of thalamic microstructural damage after Shiga toxin 2-associated hemolytic-uremic syndrome. Journal of the neurological sciences. 2015 Sep 15;356(1-2):175-83

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 26189050

    View Full Text